U.S. Exosomes Market Size, Share & Trends Analysis Report By Product & Service, By Application, By Workflow, By End Use, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Application Segment
  • 1.1.2. Product & Service Segment
  • 1.1.3. Workflow Segment
  • 1.1.4. End Use Segment
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Primary Research
• 1.5. Information or Data Analysis:
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objective

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
    • 3.2.1.2. Advanced applications of exosomes
    • 3.2.1.3. Growth in strategic initiatives for exosome-based therapies
    • 3.2.1.4. Increasing prevalence of cancer
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulations pertaining to approval
    • 3.2.2.2. Challenges associated with the implementation of exosome-based therapies
    • 3.2.2.3. Reduction in funding for biomedical research
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Exosomes Market Product & Service Estimates & Trend Analysis

• 4.1. U.S. Exosomes Product & Service Dashboard
• 4.2. U.S. Exosomes Product & Service Movement Analysis
• 4.3. Kits & Reagents
  • 4.3.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
• 4.5. Services
  • 4.5.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Exosomes Market Application & Trend Analysis

• 5.1. U.S. Exosomes Market Application Dashboard
• 5.2. U.S. Exosomes Market Application Movement Analysis
• 5.3. Cancer
  • 5.3.1. Cancer Market, 2021 - 2033 (USD Million)
• 5.4. Neurodegenerative Diseases
  • 5.4.1. Neurodegenerative Diseases Market, 2021 - 2033 (USD Million)
• 5.5. Cardiovascular Diseases
  • 5.5.1. Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
• 5.6. Infectious Diseases
  • 5.6.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Exosomes Market Workflow Estimates & Trend Analysis

• 6.1. U.S. Exosomes Market Workflow Dashboard
• 6.2. U.S. Exosomes Market Workflow Movement Analysis
• 6.3. Isolation Methods
  • 6.3.1. Isolation Methods Market, 2021 - 2033 (USD Million)
  • 6.3.2. Ultracentrifugation
    • 6.3.2.1. Ultracentrifugation Market, 2021 - 2033 (USD Million)
  • 6.3.3. Immunocapture On Beads
    • 6.3.3.1. Immunocapture On Beads Market, 2021 - 2033 (USD Million)
  • 6.3.4. Precipitation
    • 6.3.4.1. Precipitation Market, 2021 - 2033 (USD Million)
  • 6.3.5. Filtration
    • 6.3.5.1. Filtration Market, 2021 - 2033 (USD Million)
  • 6.3.6. Others
    • 6.3.6.1. Other Isolation Methods Market, 2021 - 2033 (USD Million)
• 6.4. Downstream Analysis
  • 6.4.1. Downstream Analysis Market, 2021 - 2033 (USD Million)
  • 6.4.2. Cell Surface Marker Analysis Using Flow Cytometry
    • 6.4.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market, 2021 - 2033 (USD Million)
  • 6.4.3. Protein Analysis Using Blotting & ELISA
    • 6.4.3.1. Protein Analysis Using Blotting & ELISA Market, 2021 - 2033 (USD Million)
  • 6.4.4. RNA Analysis With NGS & PCR
    • 6.4.4.1. RNA Analysis With NGS & PCR Market, 2021 - 2033 (USD Million)
  • 6.4.5. Proteomic Analysis Using Mass Spectrometry
    • 6.4.5.1. Proteomic Analysis Using Mass Spectrometry Market, 2021 - 2033 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Other Downstream Analysis Market, 2021 - 2033 (USD Million)

Chapter 7. U.S. Exosomes Market End Use Estimates & Trend Analysis

• 7.1. U.S. Exosomes Market End Use Dashboard
• 7.2. U.S. Exosomes Market End Use Movement Analysis
• 7.3. Pharmaceutical & Biotechnology Companies
  • 7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
• 7.4. Hospitals & Diagnostics Centers
  • 7.4.1. Hospitals & Diagnostics Centers Market, 2021 - 2033 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Company Market Position Analysis, 2025
• 8.3. Company Profiles
  • 8.3.1. Danaher
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Thermo Fisher Scientific, Inc.
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Hologic Inc.
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Bio-Techne
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. RoosterBio, Inc
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Fujifilm Holdings Corporation
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Lonza
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Miltenyi Biotec
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. QIAGEN
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. CellBio Scientific
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives

List of Tables

• Table 1. List of abbreviations
• Table 2. U.S. Exosomes Market, By Product, 2021 - 2033 (USD Million)
• Table 3. U.S. Exosomes Market, By Application, 2021 - 2033 (USD Million)
• Table 4. U.S. Exosomes Market, By Workflow, 2021 - 2033 (USD Million)
• Table 5. U.S. Exosomes Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 U.S. Exosomes Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 U.S. Exosomes Market: Product & service outlook and key takeaways
• Fig. 13 U.S. Exosomes Market: Product & service movement analysis & market share 2025 & 2033
• Fig. 14 Kits & reagents market, 2021 - 2033 (USD Million)
• Fig. 15 Instruments market, 2021 - 2033 (USD Million)
• Fig. 16 Services market, 2021 - 2033 (USD Million)
• Fig. 17 U.S. Exosomes Market: Application outlook and key takeaways
• Fig. 18 U.S. Exosomes Market: Application movement analysis & market share
• Fig. 19 Isolation methods market, 2021 - 2033 (USD Million)
• Fig. 20 Ultracentrifugation market, 2021 - 2033 (USD Million)
• Fig. 21 Immunocapture on beads market, 2021 - 2033 (USD Million)
• Fig. 22 Precipitation market, 2021 - 2033 (USD Million)
• Fig. 23 Filtration market, 2021 - 2033 (USD Million)
• Fig. 24 Other isolation methods market, 2021 - 2033 (USD Million)
• Fig. 25 Downstream analysis market, 2021 - 2033 (USD Million)
• Fig. 26 Cell surface marker analysis using flow cytometry market, 2021 - 2033 (USD Million)
• Fig. 27 Protein analysis using blotting & ELISA market, 2021 - 2033 (USD Million)
• Fig. 28 RNA analysis with NGS & PCR market, 2021 - 2033 (USD Million)
• Fig. 29 Proteomic analysis using mass spectroscopy market, 2021 - 2033 (USD Million)
• Fig. 30 Other downstream analysis market, 2021 - 2033 (USD Million)
• Fig. 31 U.S. Exosomes Market: Application outlook and key takeaways
• Fig. 32 U.S. Exosomes Market: Application movement analysis & market share
• Fig. 33 Cancer market, 2021 - 2033 (USD Million)
• Fig. 34 Neurodegenerative diseases market, 2021 - 2033 (USD Million)
• Fig. 35 Cardiovascular diseases market, 2021 - 2033 (USD Million)
• Fig. 36 Infectious diseases market, 2021 - 2033 (USD Million)
• Fig. 37 Other applications market, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Exosomes Market: End use outlook and key takeaways
• Fig. 39 U.S. Exosomes Market: End use movement analysis & market share
• Fig. 40 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
• Fig. 41 Hospitals & diagnostics centers market estimates and forecast, 2021 - 2033
• Fig. 42 Academic and research institutes market estimates and forecast, 2021 - 2033
• Fig. 43 Others market estimates and forecasts, 2021 - 2033